Diaverum (Hong Kong) Limited
Diaverum is a healthcare service provider specializing in chronic diseases, with a strong focus on renal care, i.e. chronic kidney disease. Depending on the market requirements and regulations we provide a wide range of medical services such as preventive care, dialysis, vascular access surgery, renal/pancreatic organ transplantations, and treatment of some comorbidities like hypertension, diabetes and cardiovascular disease.
Diaverum’s vision is to become First Choice in Renal Care, and we invest a lot in providing the highest medical service and patient satisfaction through our competent, passionate and inspiring medical staff. We operate our kidney centers either on a standalone basis, or as an integrated part of larger hospitals, often on long-term contracts with the national/regional/local healthcare authorities. The company has over the past 10 years grown rapidly through acquisitions of clinics and smaller clinic chains, and new market entries of Germany, Chile, Romania, Saudi Arabia, Russia, Kazakhstan, Brazil, North Macedonia, China, Singapore and Malaysia. Today we operate over 450 clinics in 23 countries, and have around 13,000 staff. Operated out of Hong Kong, Middle East & Asia is the fastest growing region, with Saudi Arabia having become the largest market globally in terms of number of clinics, patients and treatments performed.
Senior Management: Måns Olsson; Chief Strategy Officer, and Head of Middle East & Asia
Senior Vice President, Head of Middle East & Asia